Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130285 · ClinicalTrials.gov registry record
Validation of a Multi-gene Test for Lung Cancer Risk
A clinical trial of Lung Cancer, sponsored by University of Toledo Health Science Campus.
- Active
- Registry status
- 403
- Enrollment target
- 13
- Study locations
NCT01130285: Active study of Lung Cancer, sponsored by University of Toledo Health Science Campus.
NCT01130285 is a study of Lung Cancer that is active but no longer recruiting, run by University of Toledo Health Science Campus. The registered enrollment target is 403 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (57% lower). The trial reports 13 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01130285, a study of Lung Cancer, is active but no longer recruiting, sponsored by University of Toledo Health Science Campus.
- ACTIVE NOT RECRUITING
- Registry status
- 403 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.
Primary Outcome
Time of diagnosis of incidental lung cancer will be compared to value of the investigational device, the Lung Cancer Risk Test (LCRT).
Conditions Studied
Interventions
- GENETIC Lung Cancer Risk Test
Study Locations (13)
Ohio
- Cleveland Clinic Foundation - Cleveland
- Ohio State University - Columbus
- The Toledo Hospital - Toledo
- Mercy St. Vincent Medical Center - Toledo
- University of Toledo, Health Science Campus - Toledo
Michigan
- University of Michigan - Ann Arbor
- Henry Ford - Detroit
Tennessee
- Tennessee Valley Veterans Admin. - Nashville
- Vanderbilt - Nashville
Colorado
- National Jewish Health - Denver
Minnesota
- Mayo Clinic - Rochester
South Carolina
- Medical University of South Carolina - Charleston
Virginia
- Inova Fairfax Hospital - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2011-05 |
| Est. Completion | 2026-09 |
What the registry record for NCT01130285 still lists
NCT01130285 is an observational study that tracks outcomes without assigning an intervention. The registered 403 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Lung Cancer Risk Test is the first listed.
NCT01130285 lists 13 locations in 7 states (Ohio, Michigan, Tennessee).
Frequently Asked Questions
What is clinical trial NCT01130285 about?
NCT01130285 is a clinical study titled "Validation of a Multi-gene Test for Lung Cancer Risk". The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.
What is the current status of trial NCT01130285?
This trial is currently active not recruiting. The enrollment target is 403 participants. The study started on 2011-05. Estimated completion is 2026-09.
What conditions does trial NCT01130285 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT01130285?
The interventions under investigation include: Lung Cancer Risk Test (GENETIC).
Who is sponsoring clinical trial NCT01130285?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01130285 being conducted?
This trial has 13 study locations across Colorado, Michigan, Minnesota, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01130285's enrollment target sits among peer trials
403 80th of 409 higher than 330 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05647122 · 403 participants · Phase 1
First in Human Study of AZD9592 in Solid Tumors
- NCT05674799 · 403 participants · NA
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
- NCT06244771 · 403 participants · Phase 1
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- NCT05049057 · 404 participants · Phase 2
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia